BETTAMOUSSE: Steroid responsive dermatoses of the scalp, such as psoriasis If you require a prescription, please visit our online doctor
You will need a prescription to purchase this product. If you do not have one our On-line doctor maybe able to provide a prescription for you.
Steroid responsive dermatoses of the scalp, such as psoriasis.
Posology and method of administration
Adults, the elderly and children (over the age of six years): No more than a "golf-ball" sized amount of mousse (containing approximately 3.5mg betamethasone), or proportionately less for children, to be massaged into the affected areas of the scalp twice daily (in the morning and evening) until the condition improves. If there is no improvement after 7 days, treatment should be discontinued. Once the condition has improved, application is reduced to once a day and after daily treatment it may be possible to maintain improvement by applying even less frequently. In children over the age of 6 years, this product should not, in general, be used for longer than 5 to 7 days.
Patients should be advised to use the product sparingly.
Go to top of the page4.3 Contraindications
Bacterial, fungal, parasitic or viral infections of the scalp unless simultaneous treatment is initiated.
Hypersensitivity to the active substance or to any of the excipients.
Dermatoses in children under six years of age.
Go to top of the page4.4 Special warnings and precautions for use
Avoid contact with the eyes, open wounds and mucosae. Do not use near a naked flame.
The least amount of mousse required to control the disease should be used for the shortest possible time. This should minimise the potential for long term side effects. This is particularly the case in children, as adrenal suppression can occur even without its use with an occlusive dressing.
As with other topical corticosteroids, at least monthly clinical review is recommended if treatment is prolonged, and it may be advisable to monitor for signs of systemic activity.
The use of topical corticosteroids in psoriasis requires careful supervision. Glucocorticoids can mask, activate and worsen a skin infection. Development of secondary infection requires appropriate antimicrobial therapy and may necessitate withdrawal of topical corticosteroid therapy. Occlusive treatment should be avoided when there are signs of secondary infection. There is a risk of the development of generalised pustular psoriasis or local or systemic toxicity due to impaired barrier function of the skin.
Tolerance may develop and rebound relapse may occur on withdrawal of treatment.
Go to top of the page4.5 Interaction with other medicinal products and other forms of interaction
Not relevant to topical use.
Go to top of the page4.6 Pregnancy and lactation
There is inadequate evidence of safety in human pregnancy. Bettamousse should only be used in pregnancy or lactation if the potential benefit outweighs the risk. Topical administration of corticosteroids to pregnant animals can cause abnormalities of foetal development such as cleft palate, but the relevance of this in man is unknown. Reduced placental and birth weight have been recorded in animals and man after long-term treatment.
While betamethasone valerate passes over into the maternal milk, there appears to be little risk of therapeutic doses having an effect on the baby.
Go to top of the page4.7 Effects on ability to drive and use machines
Bettamousse has no known influence on the ability to drive and use machines.
Go to top of the page4.8 Undesirable effects
a. Prolonged use of large amounts, or treatment of extensive areas can result in sufficient systemic absorption to produce the features of hypercorticism and suppression of the hypothalamic-pituitary-adrenal axis. These effects are more likely to occur in children, and if occlusive dressings are used.
Individual cases of headache, stinging and pruritus have been described. If signs of hypersensitivity appear, application should be stopped immediately.
b. The following side effects can occur with topical use of steroids:
Other side effects include: purpura, acne (especially during prolonged application). Rarely, perioral dermatitis and systemic activity.
In rare instances, treatment of psoriasis with corticosteroids (or their withdrawal) is thought to have provoked the pustular form of the disease. (See Precautions).
Go to top of the page4.9 Overdose
Acute overdosage is very unlikely to occur. However, in the case of chronic overdosage or misuse, the features of hypercorticism may appear. In this situation topical steroids should be discontinued under careful clinical supervision, with supportive therapy if appropriate.
Go to top of the page5. PHARMACOLOGICAL PROPERTIES
Go to top of the page5.1 Pharmacodynamic properties
Pharmacotherapeutic (ATC) code: DO7AC: Corticosteroids, dermatological preparations, potent (group III).
Betamethasone is a glucocorticosteroid, which has topical anti-inflammatory activity.
Go to top of the page5.2 Pharmacokinetic properties
Under conditions of normal use, topical administration of betamethasone is not associated with clinically significant systemic absorption.
Go to top of the page5.3 Preclinical safety data
Topical administration of corticosteroids to pregnant animals has been associated with abnormalities of foetal development and growth retardation, although the relevance of this in humans is unknown.
Go to top of the page6. PHARMACEUTICAL PARTICULARS
Go to top of the page6.1 List of excipients
Citric acid anhydrous
Go to top of the page6.2 Incompatibilities
Go to top of the page6.3 Shelf life
Go to top of the page6.4 Special precautions for storage
Do not store above 25°C. Do not refrigerate.
Go to top of the page6.5 Nature and contents of container
Aluminium EP-lined Cebal can with Precision valve and clear cover cap, with a net weight of 50 or 100g.
Go to top of the page6.6 Special precautions for disposal and other handling
No special requirements.
Any unused product or waste material should be disposed of in accordance with local requirements.
Go to top of the page7. MARKETING AUTHORISATION HOLDER
UCB Pharma Limited
Asset Chemist is a registered pharmacy in the UK and is now the country\'s best value dedicated internet pharmacy. All of our content on this website is for information purposes only, and we recommend you use it as a support to the advice given to you by your healthcare providers. Please ensure you read all product packaging and labels prior to use. Please consult your doctor before using any new product. For more information view our Terms [&] Conditions.
We also provide a prescription service for you or your pet and delivery the medication direct to your door.
As an Online Pharmacy we strictly observe legal requirements in both our and your country. However, we recommend you check the importation regulations of your country to verify the laws of ordering online pharmaceuticals and over the counter medication from abroad. The buyer is responsible for determining and abiding by his/her country\'s importation regulations.
Please visit www.postoffice.co.uk/letters-parcels/mailing-guide/restricted-and-prohibited-goods